Bariatric Arterial Embolization: Current Status

Adham Khalil; Clifford R. Weiss; Andrew J. Gunn

doi:10.1055/s-0042-1750767

Digestive Disease Interventions, Inhaltsverzeichnis

Digestive Disease Interventions 2022; 06(04): 305-316
DOI: 10.1055/s-0042-1750767

Review Article

Bariatric Arterial Embolization: Current Status

Adham Khalil

¹Division of Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland

,

Clifford R. Weiss

¹Division of Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland

,

Andrew J. Gunn

²Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama

› Institutsangaben

Abstract

Obesity is a well-known major public health concern that causes significant morbidity and mortality with severe effects on the healthcare system and its financial status. Classic treatment options for obesity include lifestyle interventions, pharmacotherapy, and bariatric surgery. However, there is a treatment gap for patients in whom lifestyle modifications were not sufficient or satisfactory, and yet bariatric surgery is not a suitable option. Bariatric artery embolization (BAE) is a novel, minimally invasive, image-guided endovascular procedure that induces weight loss by reducing the production of appetite-mediating hormones following transarterial embolization of the gastric fundus. Recent evidence has shown that BAE is safe and effective in inducing clinically significant weight. This article will review the existing preclinical and clinical evidence on BAE, and discuss the future directions for this procedure.

Keywords

bariatric - embolization - weight loss

Volltext

Referenzen

References
1 National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults–the evidence report. Obes Res 1998; 6 (Suppl. 02) 51S-209S
2 Chinn S. Definitions of childhood obesity: current practice. Eur J Clin Nutr 2006; 60 (10) 1189-1194
3 Afshin A, Forouzanfar MH, Reitsma MB. et al; GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017; 377 (01) 13-27
4 Ng M, Fleming T, Robinson M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384 (9945): 766-781
5 Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care 2016; 22 (07) , Suppl): s176-s185
6 Wolfe BM, Kvach E, Eckel RH. Treatment of obesity: weight loss and bariatric surgery. Circ Res 2016; 118 (11) 1844-1855
7 Pantalone KM, Hobbs TM, Chagin KM. et al. Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system. BMJ Open 2017; 7 (11) e017583
8 Dawes AJ, Maggard-Gibbons M, Maher AR. et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA 2016; 315 (02) 150-163
9 Khaodhiar L, McCowen KC, Blackburn GL. Obesity and its comorbid conditions. Clin Cornerstone 1999; 2 (03) 17-31
10 Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009; 28 (05) w822-w831
11 Curry SJ, Krist AH, Owens DK. et al; US Preventive Services Task Force. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement. JAMA 2018; 320 (11) 1163-1171
12 Wadden TA, Webb VL, Moran CH, Bailer BA. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation 2012; 125 (09) 1157-1170
13 Franz MJ, VanWormer JJ, Crain AL. et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007; 107 (10) 1755-1767
14 Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 2001; 74 (05) 579-584
15 Jensen MD, Ryan DH, Apovian CM. et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 2014; 63 (25, Pt B): 2985-3023
16 Srivastava G, Apovian CM. Current pharmacotherapy for obesity. Nat Rev Endocrinol 2018; 14 (01) 12-24
17 Khera R, Murad MH, Chandar AK. et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA 2016; 315 (22) 2424-2434
18 Picot J, Jones J, Colquitt JL. et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009; 13 (41) 1-190 , 215–357, iii–iv
19 Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol 2017; 14 (03) 160-169
20 Weiss CR, Kathait AS. Bariatric embolization: a new and effective option for the obese patient?. Expert Rev Gastroenterol Hepatol 2017; 11 (04) 293-302
21 Yuan F, Latif MA, Shafaat O. et al. Interventional radiology obesity therapeutics: proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. J Vasc Interv Radiol 2021; 32 (09) 1388.e1-1388.e14
22 Paz-Filho G, Mastronardi CA, Licinio J. Leptin treatment: facts and expectations. Metabolism 2015; 64 (01) 146-156
23 Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8 (01) 21-34
24 Gale SM, Castracane VD, Mantzoros CS. Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr 2004; 134 (02) 295-298
25 Perry B, Wang Y. Appetite regulation and weight control: the role of gut hormones. Nutr Diabetes 2012; 2: e26
26 Hosoda H, Kojima M, Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 2006; 100 (05) 398-410
27 Wellman M, Abizaid A. Knockdown of central ghrelin O-acyltransferase by vivo-morpholino reduces body mass of rats fed a high-fat diet. Peptides 2015; 70: 17-22
28 Wellman PJ, Clifford PS, Rodriguez JA. Ghrelin and ghrelin receptor modulation of psychostimulant action. Front Neurosci 2013; 7: 171
29 Goitein D, Lederfein D, Tzioni R, Berkenstadt H, Venturero M, Rubin M. Mapping of ghrelin gene expression and cell distribution in the stomach of morbidly obese patients – a possible guide for efficient sleeve gastrectomy construction. Obes Surg 2012; 22 (04) 617-622
30 Arepally A, Barnett BP, Montgomery E, Patel TH. Catheter-directed gastric artery chemical embolization for modulation of systemic ghrelin levels in a porcine model: initial experience. Radiology 2007; 244 (01) 138-143
31 Arepally A, Barnett BP, Patel TH. et al. Catheter-directed gastric artery chemical embolization suppresses systemic ghrelin levels in porcine model. Radiology 2008; 249 (01) 127-133
32 Paxton BE, Arepally A, Alley CL, Kim CY. Bariatric embolization: pilot study on the impact of gastroprotective agents and arterial distribution on ulceration risk and efficacy in a porcine model. J Vasc Interv Radiol 2016; 27 (12) 1923-1928
33 Paxton BE, Kim CY, Alley CL. et al. Bariatric embolization for suppression of the hunger hormone ghrelin in a porcine model. Radiology 2013; 266 (02) 471-479
34 Bawudun D, Xing Y, Liu WY. et al. Ghrelin suppression and fat loss after left gastric artery embolization in canine model. Cardiovasc Intervent Radiol 2012; 35 (06) 1460-1466
35 Kim JM, Kim MD, Han K. et al. Bariatric arterial embolization with non-spherical polyvinyl alcohol particles for ghrelin suppression in a swine model. Cardiovasc Intervent Radiol 2017; 40 (05) 744-749
36 Fu Y, Weiss CR, Paudel K. et al. Bariatric arterial embolization: effect of microsphere size on the suppression of fundal ghrelin expression and weight change in a swine model. Radiology 2018; 289 (01) 83-89
37 Diana M, Pop R, Beaujeux R. et al. Embolization of arterial gastric supply in obesity (EMBARGO): an endovascular approach in the management of morbid obesity. Proof of the concept in the porcine model. Obes Surg 2015; 25 (03) 550-558
38 Weiss CR, Fu Y, Beh C. et al. Bariatric arterial embolization with calibrated radiopaque microspheres and an antireflux catheter suppresses weight gain and appetite-stimulating hormones in swine. J Vasc Interv Radiol 2020; 31 (09) 1483-1491
39 Paxton BE, Alley CL, Crow JH. et al. Histopathologic and immunohistochemical sequelae of bariatric embolization in a porcine model. J Vasc Interv Radiol 2014; 25 (03) 455-461
40 Weiss CR, Abiola GO, Fischman AM. et al. Bariatric Embolization of Arteries for the Treatment of Obesity (BEAT Obesity) trial: results at 1 year. Radiology 2019; 291 (03) 792-800
41 Weiss CR, Akinwande O, Paudel K. et al. Clinical safety of bariatric arterial embolization: preliminary results of the BEAT Obesity trial. Radiology 2017; 283 (02) 598-608
42 Pirlet C, Ruzsa Z, Costerousse O. et al. Transradial left gastric artery embolization to treat severe obesity: a pilot study. Catheter Cardiovasc Interv 2019; 93 (03) 365-370
43 Syed MI, Morar K, Shaikh A. et al. Gastric Artery Embolization Trial for the Lessening of Appetite Nonsurgically (GET LEAN): six-month preliminary data. J Vasc Interv Radiol 2016; 27 (10) 1502-1508
44 Elens S, Roger T, Elens M. et al. Gastric embolization as treatment for overweight patients; efficacy and safety. Cardiovasc Intervent Radiol 2019; 42 (04) 513-519
45 Pasciak AS, Bourgeois AC, Paxton BE. et al. Bariatric radioembolization: a pilot study on technical feasibility and safety in a porcine model. J Vasc Interv Radiol 2016; 27 (10) 1509-1517
46 Kipshidze N, Archvadze A, Bertog S, Leon MB, Sievert H. Endovascular bariatrics: first in humans study of gastric artery embolization for weight loss. JACC Cardiovasc Interv 2015; 8 (12) 1641-1644
47 Levigard RB, Serrão H, Castro C. et al. Bariatric embolization in the treatment of patients with a body mass index between 30 and 39.9 kg/m² (obesity class I and II) and metabolic syndrome, a pilot study. Cardiovasc Intervent Radiol 2021; 44 (04) 598-606
48 Reddy VY, Neužil P, Musikantow D. et al. Transcatheter bariatric embolotherapy for weight reduction in obesity. J Am Coll Cardiol 2020; 76 (20) 2305-2317
49 Zaitoun MMA, Basha MAA, Hassan F. et al. Left gastric artery embolization in obese, prediabetic patients: a pilot study. J Vasc Interv Radiol 2019; 30 (06) 790-796
50 Bai ZB, Qin YL, Deng G, Zhao GF, Zhong BY, Teng GJ. Bariatric embolization of the left gastric arteries for the treatment of obesity: 9-month data in 5 patients. Obes Surg 2018; 28 (04) 907-915
51 Vairavamurthy J, Cheskin LJ, Kraitchman DL, Arepally A, Weiss CR. Current and cutting-edge interventions for the treatment of obese patients. Eur J Radiol 2017; 93: 134-142
52 Caine M, Zhang X, Hill M. et al. Comparison of microsphere penetration with LC Bead LUMI™ versus other commercial microspheres. J Mech Behav Biomed Mater 2018; 78: 46-55
53 Weiss CR, Gunn AJ, Kim CY, Paxton BE, Kraitchman DL, Arepally A. Bariatric embolization of the gastric arteries for the treatment of obesity. J Vasc Interv Radiol 2015; 26 (05) 613-624
54 Khalilzadeh O, Baerlocher MO, Shyn PB. et al. Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol 2017; 28 (10) 1432-1437.e3
55 Hafezi-Nejad N, Bailey CR, Gunn AJ, Weiss CR. Weight loss after left gastric artery embolization: a systematic review and meta-analysis. J Vasc Interv Radiol 2019; 30 (10) 1593-1603.e3
56 Gunn AJ, Weiss CR. Is there a role for bariatric embolization in the treatment of the diabetic patient?. J Vasc Interv Radiol 2019; 30 (06) 797-800
57 Pulkkinen L, Ukkola O, Kolehmainen M, Uusitupa M. Ghrelin in diabetes and metabolic syndrome. Int J Pept 2010; 2010: 248948
58 Akinwande O, Akinwande O, Holly B. et al. FEATURED ABSTRACT Recanalization/collateralization after bariatric embolization in a swine model: comparison between 40 μm, 100–300 μm and 300–500 μm embolic microspheres. J Vasc Interv Radiol 2016; 27 (03) S9
59 Ashour MA, Karsou AS, Bakhsh AA. Uneventful sleeve gastrectomy post bariatric arterial embolization. Arab J Intervent Radiol 2021; 4 (02) 127-129